APA (7th ed.) Citation

Penna, G., Allegra, A., Alonci, A., Aguennouz, M., Garufi, A., Cannavò, A., . . . Musolino, C. (2011). MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: An impact on susceptibility and prognosis. Medical oncology (Northwood, London, England), 28(4), 1549-1554. https://doi.org/10.1007/s12032-010-9561-9

Chicago Style (17th ed.) Citation

Penna, G., A. Allegra, A. Alonci, M. Aguennouz, A. Garufi, A. Cannavò, D. Gerace, A. Alibrandi, and C. Musolino. "MDR-1 Polymorphisms (G2677T and C3435T) in B-chronic Lymphocytic Leukemia: An Impact on Susceptibility and Prognosis." Medical Oncology (Northwood, London, England) 28, no. 4 (2011): 1549-1554. https://doi.org/10.1007/s12032-010-9561-9.

MLA (9th ed.) Citation

Penna, G., et al. "MDR-1 Polymorphisms (G2677T and C3435T) in B-chronic Lymphocytic Leukemia: An Impact on Susceptibility and Prognosis." Medical Oncology (Northwood, London, England), vol. 28, no. 4, 2011, pp. 1549-1554, https://doi.org/10.1007/s12032-010-9561-9.